Monthly Archives: November 2023

Mass Production of Accurate, 30-Second Blood Type Test Kit Set for Next Year

Chongqing – Gone are the days of hospital visits, lengthy waits, and cumbersome procedures for blood type identification. A simple test strip, which will soon be purchasable for home use next year, can determine one’s blood type in 30 seconds.  Southwest China’s Chongqing has introduced a revolutionary method of blood typing, an innovation that can vastly […]

What you need to know about COVID and vaccines now

Normal text sizeLarger text sizeVery large text size NSW is in the grip of its eighth COVID-19 wave with the latest NSW Health data revealing that infection rates have doubled since the beginning of October. Released on Thursday, the data shows a 16 per cent increase in community infections in the fortnight to November 18, […]

Federal officials investigating new outbreak of Salmonella Newport infections

The Food and Drug Administration is investigating a new outbreak of dozens of infections caused by Salmonella Newport. As of November 22, the agency reported 40 confirmed patients in the outbreak. The FDA has begun traceback efforts but has not reported what food or foods are being traced. The FDA has not reported where the […]

Natural killer cell subsets in deep vein thrombosis

Introduction Venous thromboembolism (VTE) is the third most common cardiovascular disease affecting approximately 2% of the population. VTE is a critical condition that may result as a complication of many diseases such as cancer, major trauma, surgery, and systemic diseases. Therefore, VTE is considered an economic health problem worldwide.1–3 An important mechanism in the pathogenesis […]

Algorae, Monash University Collaborate on Pre-Clinical Studies for Cardiovascular Diseases Drug; Shares Plunge 8%

Algorae Pharmaceuticals Limited, formerly Living Cell Technologies Limited, is an Australia-based pharmaceutical development company. The Company is focused on discovering and developing novel treatments for medical conditions with under met medical needs. Its programs include AlgoraeOS, Dementia and Parkinson’s. Its drug candidates include NTCELL for Parkinson’s disease and the AI-116 combination drug candidate for dementia. […]

COVID-19 vaccination before first infection may reduce risk of developing long COVID

Receiving at least one dose of a covid-19 vaccine before the first infection is strongly associated with a reduced risk of developing post-covid-19 condition, commonly known as long covid, finds a study published by The BMJ today. The findings, based on data for more than half a million Swedish adults, show that unvaccinated individuals were […]

Antimicrobial resistance: How misuse of medicines is making infections difficult to treat – Experts

As Nigeria joins the rest of the world to mark this year’s World Antimicrobial Resistance Awareness Week (WAAW), experts say there is need for increased awareness and efforts among the population, government and policymakers towards preventing and reducing further emergence and spread of Antimicrobial Resistance (AMR).  They said AMR has become a threat to humans, […]

WHO asks China for more details on unexplained pneumonia outbreak

Reports that children’s hospitals in Beijing, Liaoning and other cities are ‘overwhelmed with sick children’. The World Health Organization (WHO) has asked Beijing for more information on an outbreak of mysterious pneumonia in northern China that appears mostly to be affecting children. The WHO made “an official request for detailed information on an increase in […]